Independent Director, HCIA.

Appointed to the HCIA Board 1 July 2021, after serving as an HCIA member since 2008. Nina is a qualified audiologist, who has worked for Government providers, industry manufacturers and served as the Managing Director, Neurosensory (2008-2024). Nina was the audiologist representative on the OHNS Clinical Committee as part of the Medicare Taskforce (2018- 2023), has been an Audiology Australia federal councillor, and has worked on numerous taskforces and committees, aimed at improving the access to, and quality of, hearing care for Australians.  
 
As a HCIA Board member, Nina is committed to ensuring clinically appropriate hearing healthcare services are accessible to everyone irrespective of age or where they live; developing, valuing, and growing clinical hearing healthcare professionals to enhance the quality and accessibility of hearing services in Australia; and fundamentally a commitment to lifetime hearing healthcare for Australians.

Nina has an MBA, is a qualified Audiologist with a Bachelor of Science, a Graduate member of the Australian Institute of Company Directors and currently is the CEO of Queensland Cardiovascular Group.